These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

745 related items for PubMed ID: 15697327

  • 1. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
    Versiani M, Moreno R, Ramakers-van Moorsel CJ, Schutte AJ, Comparative Efficacy Antidepressants Study Group.
    CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
    Leinonen E, Skarstein J, Behnke K, Agren H, Helsdingen JT.
    Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
    [Abstract] [Full Text] [Related]

  • 3. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.
    Guelfi JD, Ansseau M, Timmerman L, Kørsgaard S, Mirtazapine-Venlafaxine Study Group.
    J Clin Psychopharmacol; 2001 Aug; 21(4):425-31. PubMed ID: 11476127
    [Abstract] [Full Text] [Related]

  • 4. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.
    Wheatley DP, van Moffaert M, Timmerman L, Kremer CM.
    J Clin Psychiatry; 1998 Jun; 59(6):306-12. PubMed ID: 9671343
    [Abstract] [Full Text] [Related]

  • 5. A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.
    Hong CJ, Hu WH, Chen CC, Hsiao CC, Tsai SJ, Ruwe FJ.
    J Clin Psychiatry; 2003 Aug; 64(8):921-6. PubMed ID: 12927007
    [Abstract] [Full Text] [Related]

  • 6. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS, Ng F, Berk M.
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [Abstract] [Full Text] [Related]

  • 7. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.
    Schatzberg AF, Kremer C, Rodrigues HE, Murphy GM, Mirtazapine vs. Paroxetine Study Group.
    Am J Geriatr Psychiatry; 2002 Apr; 10(5):541-50. PubMed ID: 12213688
    [Abstract] [Full Text] [Related]

  • 8. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia.
    Winokur A, DeMartinis NA, McNally DP, Gary EM, Cormier JL, Gary KA.
    J Clin Psychiatry; 2003 Oct; 64(10):1224-9. PubMed ID: 14658972
    [Abstract] [Full Text] [Related]

  • 9. Mirtazapine compared with paroxetine in major depression.
    Benkert O, Szegedi A, Kohnen R.
    J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
    [Abstract] [Full Text] [Related]

  • 10. A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients.
    Høyberg OJ, Maragakis B, Mullin J, Norum D, Stordall E, Ekdahl P, Ose E, Moksnes KM, Sennef C.
    Acta Psychiatr Scand; 1996 Mar; 93(3):184-90. PubMed ID: 8739664
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in austria.
    Brown MC, Nimmerrichter AA, Guest JF.
    Eur Psychiatry; 1999 Jul; 14(4):230-44. PubMed ID: 10572352
    [Abstract] [Full Text] [Related]

  • 12. Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.
    Benkert O, Szegedi A, Philipp M, Kohnen R, Heinrich C, Heukels A, van der Vegte-Senden M, Baker RA, Simmons JH, Schutte AJ.
    J Clin Psychopharmacol; 2006 Feb; 26(1):75-8. PubMed ID: 16415711
    [Abstract] [Full Text] [Related]

  • 13. Mirtazapine versus selective serotonin reuptake inhibitors.
    Thompson C.
    J Clin Psychiatry; 1999 Feb; 60 Suppl 17():18-22; discussion 46-8. PubMed ID: 10446737
    [Abstract] [Full Text] [Related]

  • 14. A risk-benefit assessment of mirtazapine in the treatment of depression.
    Kasper S, Praschak-Rieder N, Tauscher J, Wolf R.
    Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
    [Abstract] [Full Text] [Related]

  • 15. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
    Smith WT, Glaudin V, Panagides J, Gilvary E.
    Psychopharmacol Bull; 1990 Oct; 26(2):191-6. PubMed ID: 2236455
    [Abstract] [Full Text] [Related]

  • 16. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.
    van Moffaert M, de Wilde J, Vereecken A, Dierick M, Evrard JL, Wilmotte J, Mendlewicz J.
    Int Clin Psychopharmacol; 1995 Mar; 10(1):3-9. PubMed ID: 7622801
    [Abstract] [Full Text] [Related]

  • 17. Relationships among measures of treatment outcome in depressed patients.
    Mulder RT, Joyce PR, Frampton C.
    J Affect Disord; 2003 Sep; 76(1-3):127-35. PubMed ID: 12943942
    [Abstract] [Full Text] [Related]

  • 18. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.
    Roose SP, Nelson JC, Salzman C, Hollander SB, Rodrigues H, Mirtazapine in the Nursing Home Study Group.
    Curr Med Res Opin; 2003 Sep; 19(8):737-46. PubMed ID: 14687445
    [Abstract] [Full Text] [Related]

  • 19. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K, Søgaard J, Martin S, Bäuml J, Ravindran AV, Agren H, Vester-Blokland ED.
    J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
    [Abstract] [Full Text] [Related]

  • 20. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
    Blier P, Gobbi G, Turcotte JE, de Montigny C, Boucher N, Hébert C, Debonnel G.
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.